Research brief · Growth Hormone
Tesamorelin
Stabilised GHRH analogue, prominent in visceral fat research models.
Class
Stabilized GHRH analogue
Half-life
~25–40 min
Studied in
Visceral adipose tissue, lipid profile studies.
What it is
Tesamorelin is a stabilised GHRH analogue with a trans-3-hexenoic acid N-terminal cap that resists DPP-4 cleavage. It is widely cited in visceral adipose tissue and lipid metabolism research.
Mechanism studied
Trans-3-hexenoic acid N-terminal modification for proteolytic resistance.
Research notes
- Often selected when visceral adipose endpoints are the focus.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.